Regulation of osteoblast differentiation mediated by BMP, Notch, and CCN3/NOV

Japanese Dental Science Review

Volumn 44, Issue 1, 2008, Pages 48-56

  Yamaguchi, Akira ^a   Sakamoto, Kei ^a   Minamizato, Tokutarou ^a,b   Katsube, Kenichi ^a   Nakanishi, Shoichi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

BMP; CCN3 NOV; Notch; Osteoblast

Indexed keywords

EID: 53549111901     PISSN: 18827616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdsr.2007.11.003     Document Type: Review

References (77)

1. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
2. Yamaguchi A., Katagiri T., Ikeda T., Wozney J.M., Rosen V., Wang E.A., et al. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113 (1991) 681-687
3. Yamaguchi A., Komori T., and Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21 (2000) 393-411
4. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 127 (1994) 1755-1766
5. Urist M.R. Bone: formation by autoinduction. Science 150 (1965) 893-899
6. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 (1997) 747-754
7. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., et al. Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20 (2000) 8783-8792
8. Lee M.H., Kim Y.J., Kim H.J., Park H.D., Kang A.R., Kyung H.M., et al. BMP-2-induced Runx2 expression is mediated by Dlx5, and TGF-beta 1 opposes the BMP-2-induced osteoblast differentiation by suppression of Dlx5 expression. J Biol Chem 278 (2003) 34387-34394
9. Celil A.B., and Campbell P.G. BMP-2 and insulin-like growth factor-I mediate Osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J Biol Chem 280 (2005) 31353-31359
10. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., and Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem Biophys Res Commun 309 (2003) 689-694
11. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89 (1997) 755-764
12. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89 (1997) 765-771
13. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108 (2002) 17-29
14. Bolos V., Grego-Bessa J., and de la Pompa J.L. Notch signaling in development and cancer. Endocr Rev 28 (2007) 339-363
15. Fiuza U.-M., and Arias A.M. Cell and molecular biology of Notch. J Endocrinol 194 (2007) 459-474
16. Dahlqvist C., Blokzijil A., Chapman G., Falk A., Dannaeus K., Ibanez C.F., et al. Functional Notch signaling is required for BMP4-induced inhibition of myogenic differentiation. Development 130 (2003) 6089-6099
17. Itoh F., Itoh S., Goumans M.-J., Valdimarsdottir G., Iso T., Dotto G.P., et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J 23 (2004) 541-551
18. Herpin A., and Cunningham C. Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes. FEBS J 274 (2007) 2977-2985
19. Nobta M., Tsukazaki T., Shibata Y., Chang X., Moriishi T., Sakano S., et al. Critical regulation of BMP-induced osteoblastic differentiation by Delta1/Jagged1-activated Notch1 signaling. J Biol Chem 280 (2005) 15842-15848
20. Nofziger D., Miyamoto A., Lyons K.M., and Weinmaster G. Notch signaling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126 (1999) 1689-1702
21. Tezuka K., Yasuda M., Watanabe N., Morimura N., Kuroda K., Miyatani S., et al. Stimulation of osteoblastic cell differentiation by Notch. J Bone Miner Res 17 (2002) 231-239
22. Sciaudone M., Gazzerro E., Priest L., Delany A.M., and Canalis E. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 144 (2003) 5631-5639
23. Deregowski V., Gazzerro E., Priest L., Rydziel S., and Canalis E. Notch 1 overexpression inhibits osteoblastogenesis by suppressing Wnt/beta-catenin but not bone morphogenetic protein signaling. J Biol Chem 281 (2006) 6203-6210
24. Sakamoto K., Yamaguchi S., Ando R., Miyawaki A., Kabasawa Y., Takagi M., et al. The nephroblastoma overexpressed gene (NOV/ccn3) protein associates with Notch1 extracellular domain and inhibits myoblast differentiation via Notch signaling pathway. J Biol Chem 277 (2002) 29399-29405
25. Calhabeu F., Lafont J., Le Dreau G., Laurent M., Kazazian C., Schaeffer L., et al. NOV/CCN3 impairs muscle cell commitment and differentiation. Exp Cell Res 312 (2006) 1876-1889
26. Takigawa M., Nakanishi T., Kubota S., and Nishida T. Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol 194 (2003) 256-266
27. Lafont J., Jacques C., Le Dreau G., Calhabeu F., Thibout H., Dubois C., et al. New target genes for NOV/CCN3 in chondrocytes: TGF-beta2 and type X collagen. J Bone Miner Res 20 (2005) 2213-2223
28. Nishida T., Nakanishi T., Asano M., Shimo T., and Takigawa M. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol 184 (2000) 197-206
29. Luo Q., Kang Q., Si W., Jiang W., Park J.K., Peng Y., et al. Connective tissue growth factor (CTGF) is regulated by Wnt and bone morphogenetic proteins signaling in osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279 (2004) 55958-55968
30. Si W., Kang Q., Luu H.H., Park J.K., Luo Q., Song W.X., et al. CCN1/Cyr61 is regulated by the canonical Wnt signal and plays an important role in Wnt3A-induced osteoblast differentiation of mesenchymal stem cells. Mol Cell Biol 26 (2006) 2955-2964
31. Minamizato T., Sakamoto K., Liu T., Kokubo H., Katsube K., Perbal B., et al. CCN3/NOV inhibits BMP-2-induced osteoblast differentiation by interacting with BMP and Notch signaling pathways. Biochem Biophys Res Commun 354 (2007) 567-573
32. Abreu J.G., Ketpura N.I., Reversade B., and De Robertis E.M. Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol 4 (2002) 599-604
33. Heldin C.H., Miyazono K., and Ten Dijke P. TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390 (1997) 465-471
34. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., Ten Dijke P., et al. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc Natl Acad Sci USA 92 (1995) 7632-7636
35. Nohno T., Ishikawa T., Saito T., Hosokawa K., Noji S., Wolsing D.H., et al. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J Biol Chem 270 (1995) 22522-22526
36. Massaous J., and Hata A. TGF-beta signaling through the Smad pathway. Trends Cell Biol 7 (1997) 187-192
37. Leivonen S.-K., and Kähäri V.-M. Transforming growth factor-β signaling in cancer invasion and metastasis. Int J Cancer 121 (2007) 2119-2124
38. Hoodless P.A., Haerry T., Abdollah S., Staplenton M., O'Conner M.B., Attisano L., et al. MADR1, a MAD-related protein that functions in BMP2 signaling pathway. Cell 85 (1996) 489-500
39. Graff J.M., Bansal A., and Melton D.A. Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85 (1996) 479-487
40. Liu F., Hata A., Baker J.C., Doody J., Cárcamo J., Harland R.M., et al. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381 (1996) 620-623
41. Kretzschmar M., Liu F., Hata A., Doody J., and Massagué J. The TGF-β family mediator Smad1 is phospholyrated directly and activated functionally by the BMP receptor kinase. Genes Dev 11 (1997) 984-995
42. Zhang Y., Feng X.H., Wu R.Y., and Derynck R. Receptor-associated Mad homologues synergize as effectors of TGF-β response. Nature 383 (1996) 168-172
43. Hayashi H., Abdollah S., Qiu Y., Cai J., Xu Y.Y., Grinnell B.W., et al. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89 (1997) 1165-1173
44. Imamura T., Takase M., Nishihara A., Oeda E., Hanai J., Kawabata M., et al. Smad6 inhibits signaling by the TGF-β superfamily. Nature 389 (1997) 622-626
45. Hata A., Lagna G., Massagué J., and Hemmati-Brivanlou A. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12 (1998) 186-197
46. Canalis E., Economides A.N., and Gazzerro E. Bone morphogenetic proteins, their antagonists, and the skeleton. Endocr Rev 24 (2003) 218-235
47. Zimmerman L.B., De Jesús-Escobar J.M., and Harland R.M. The Spemann organizer signal noggin bonds and inactivates bone morphogenetic protein 4. Cell 86 (1996) 599-606
48. Piccolo S., Sasai Y., Lu B., and De Robertis E.M. Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86 (1996) 589-598
49. Hsu D.R., Economides A.N., Wang X., Eimon P.M., and Harland R.M. The Xenopus dorsaling factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol Cell 1 (1998) 673-683
50. Brunet L.J., McMahon J.A., McMahon A.P., and Harland R.M. Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton. Science 280 (1998) 1455-1457
51. Katagiri T., Yamaguchi A., Ikeda T., Yoshiki S., Wozney J.M., Rosen V., et al. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem Biophy Res Commun 172 (1990) 295-299
52. Asahina I., Sampath T.K., and Hauschka P.V. Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells. Exp Cell Res 222 (1996) 38-47
53. Yamaguchi A., and Kahn A.J. Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int 49 (1991) 221-225
54. Wada Y., Kataoka H., Yokose S., Ishizuya T., Miyazono K., Gao Y.H., et al. Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvarial cells. Bone 22 (1998) 479-485
55. Tsuji K., Bandyopadhyay A., Harfe B.D., Cox K., Kakar S., Gerstenfeld L., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38 (2006) 1424-1429
56. Lubman O.Y., Korolev S.V., and Kopan R. Anchoring notch genetics and biochemistry; structural analysis of the ankyrin domain sheds light on existing data. Mol Cell 13 (2004) 619-626
57. Sakamoto K., Chao W.S., Katsube K., and Yamaguchi A. Distinct roles of EGF repeats for the Notch signaling system. Exp Cell Res 302 (2005) 281-291
58. Sestan N., Artavanis-Tsakonas S., and Rakic P. Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science 286 (1999) 741-746
59. Hansson E.M., Lendahl U., and Chapman G. Notch signaling in development and disease. Semin Cancer Biol 14 (2004) 320-328
60. Shindo K., Kawashima N., Sakamoto K., Yamaguchi A., Umezawa A., Takagi M., et al. Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signalling. Exp Cell Res 290 (2003) 370-380
61. Blokzijl A., Dahlqvist C., Reissmann E., Falk A., Moliner A., Lendahl U., et al. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 163 (2003) 723-728
62. Takizawa T., Ochiai W., Nakashima K., and Taga T. Enhanced gene activation by Notch and BMP signaling cross-talk. Nucleic Acids Res 31 (2003) 5723-5731
63. de Jong D.S., Steegenga W.T., Hendriks J.M., van Zoelen E.J., Olijve W., and Dechering K.J. Regulation of Notch signaling genes during BMP2-induced differentiation of osteoblast precursor cells. Biochem Biophys Res Commun 320 (2004) 100-107
64. Zamurovic N., Cappellen D., Rohner D., and Susa M. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 279 (2004) 37704-37715
65. Perbal B., Martinerie C., Sainson R., Werner M., He B., and Roizman B. The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: a clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci USA 96 (1999) 869-874
66. Perbal B. The CCN family of genes: a brief history. Mol Pathol 54 (2001) 103-104
67. Gupta N., Wang H., McLeod T.L., Naus C.C., Kyurkchiev S., Advani S., et al. Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54 (2001) 293-299
68. Natarajan D., Andermarcher E., Schofield P.N., and Boulter C.A. Mouse Nov gene is expressed in hypaxial musculature and cranial structures derived from neural crest cells and placodes. Dev Dyn 219 (2000) 417-425
69. Crowe R., Zikherman J., and Niswander L. Delta-1 negatively regulates the transition from prehypertrophic to hypertrophic chondrocytes during cartilage formation. Development 126 (1999) 987-998
70. Kocialkowski S., Yeger H., Kingdom J., Perbal B., and Schofield P.N. Expression of the human NOV gene in first trimester fetal tissues. Anat. Embryol 203 (2001) 417-427
71. Lindner V., Booth C., Prudovsky I., Small D., Maciag T., and Liaw L. Members of the Jagged/Notch gene families are expressed in injured arteries and regulate cell phenotype via alterations in cell matrix and cell-cell interaction. Am J Pathol 159 (2001) 875-883
72. Ellis P.D., Chen Q., Barker P.J., Metcalfe J.C., and Kemp P.R. Nov gene encodes adhesion factor for vascular smooth muscle cells and is dynamically regulated in response to vascular injury. Arterioscler Thromb Vasc Biol 20 (2000) 1912-1919
73. Lee J.S., Thomas D.M., Gutierrez G., Carty S.A., Yanagawa S., and Hinds P.W. HES1 cooperates with pRb to activate RUNX2-dependent transcription. J Bone Miner Res 21 (2006) 921-933
74. Rydziel S., Stadmeyer L., Zanotti S., Durant D., Smerdel-Ramoya A., and Canalis E. Nephroblastoma overexpressed (Nov) inhibits osteoblastogenesis and causes osteopenia. J Biol Chem 282 (2007) 19762-19772
75. Gupta R., Hong D., Iborra F., Sarno S., and Enver T. NOV(CCN3) functions as a regulator of human hematopoietic stem or progenitor cell. Science 316 (2007) 590-593
76. Arai F., Hirao A., Ohmura M., Sato H., Matsuoka S., Takubo K., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
77. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., et al. Novel regulators of bone formation: molecular clones and activities. Science 242 (1988) 1528-1534